| 2.4401 1.19 (95.21%) | 10-07 12:34 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.95 |
1-year : | 4.62 |
| Resists | First : | 3.39 |
Second : | 3.95 |
| Pivot price | 2.44 |
|||
| Supports | First : | 2.02 |
Second : | 1.17 |
| MAs | MA(5) : | 2.19  |
MA(20) : | 2.41 |
| MA(100) : | 79.24 |
MA(250) : | 4523.69 |
|
| MACD | MACD : | -3.2 |
Signal : | -4.5 |
| %K %D | K(14,3) : | 28 |
D(3) : | 32.4 |
| RSI | RSI(14): 31.6 |
|||
| 52-week | High : | 83760 | Low : | 1.17 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SXTC ] has closed above bottom band by 40.4%. Bollinger Bands are 97.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 39 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.06 - 2.08 | 2.08 - 2.09 |
| Low: | 1.16 - 1.17 | 1.17 - 1.18 |
| Close: | 1.23 - 1.25 | 1.25 - 1.26 |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Wed, 07 Oct 2026
SXTC Stock Volatility Spikes As Traders Eye Deep Value - StocksToTrade
Wed, 07 Oct 2026
SXTC Stock Whipsaws As Traders Track Volatile Reversal Setup - Timothy Sykes
Wed, 07 Oct 2026
SXTC Stock Whipsaws As Traders Hunt Momentum - StocksToTrade
Wed, 07 Oct 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Wed, 07 Oct 2026
SXTC Stock Whipsaws As Traders Target Extreme Volatility - Timothy Sykes
Wed, 07 Oct 2026
SXTC Stock Slides As Traders Weigh Cash-Rich Balance Sheet - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 1 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 33.3 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 26 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -730.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 31.01 |
| Profit Margin | 0 % |
| Operating Margin | -153.3 % |
| Return on Assets (ttm) | -15.8 % |
| Return on Equity (ttm) | -27.5 % |
| Qtrly Rev. Growth | -44 % |
| Gross Profit (p.s.) | 0.46 |
| Sales Per Share | 2.13 |
| EBITDA (p.s.) | -13.21 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0.07 |
| Price to Sales | 1.07 |
| Price to Cash Flow | -0.31 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|